Related Articles
Molecular alterations of the NF2 gene in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Evaluation of glypican‑3 in patients with hepatocellular carcinoma
Expression of hepatocyte markers in mass-forming peripheral and periductal-infiltrating hilar intrahepatic cholangiocarcinomas
Progress and prospects of biomarkers in primary liver cancer (Review)
Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.